DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Analysts at Barrington Research decreased their Q1 2025 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a research report issued on Friday, November 8th. Barrington Research analyst M. Petusky now forecasts that the medical instruments supplier will earn $0.38 per share for the quarter, down from their prior estimate of $0.51. Barrington Research has a "Outperform" rating and a $24.00 price objective on the stock. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. Barrington Research also issued estimates for DENTSPLY SIRONA's Q2 2025 earnings at $0.49 EPS, Q3 2025 earnings at $0.52 EPS, Q4 2025 earnings at $0.57 EPS and FY2025 earnings at $1.95 EPS.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to analysts' expectations of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm's quarterly revenue was up .4% compared to the same quarter last year. During the same quarter last year, the business posted $0.49 EPS.
Several other analysts have also recently commented on XRAY. Needham & Company LLC lowered their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating for the company in a report on Friday, October 25th. Leerink Partners downgraded shares of DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a report on Thursday. Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating on the stock in a research note on Friday. Evercore ISI lowered their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating for the company in a research note on Tuesday, October 8th. Finally, StockNews.com upgraded DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Wednesday, November 6th. Six investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, DENTSPLY SIRONA presently has an average rating of "Hold" and a consensus price target of $29.50.
View Our Latest Research Report on DENTSPLY SIRONA
DENTSPLY SIRONA Trading Down 1.2 %
Shares of NASDAQ XRAY traded down $0.21 during midday trading on Monday, reaching $17.65. 5,276,088 shares of the stock were exchanged, compared to its average volume of 3,125,136. The stock has a 50 day moving average price of $24.52 and a 200-day moving average price of $25.74. The company has a current ratio of 1.25, a quick ratio of 0.87 and a debt-to-equity ratio of 0.72. The company has a market capitalization of $3.58 billion, a P/E ratio of -8.53, a P/E/G ratio of 0.97 and a beta of 1.02. DENTSPLY SIRONA has a 52-week low of $17.21 and a 52-week high of $37.60.
Institutional Trading of DENTSPLY SIRONA
Hedge funds and other institutional investors have recently made changes to their positions in the stock. UMB Bank n.a. grew its holdings in DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock worth $25,000 after acquiring an additional 753 shares in the last quarter. Capital Performance Advisors LLP acquired a new position in DENTSPLY SIRONA in the third quarter worth about $27,000. LRI Investments LLC increased its holdings in DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock valued at $31,000 after buying an additional 564 shares during the last quarter. Kennebec Savings Bank acquired a new stake in DENTSPLY SIRONA during the third quarter valued at approximately $35,000. Finally, Rothschild Investment LLC bought a new position in DENTSPLY SIRONA during the 2nd quarter worth approximately $32,000. Institutional investors own 95.70% of the company's stock.
About DENTSPLY SIRONA
(
Get Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
